» Articles » PMID: 18413359

Association of Site-specific and Participant-specific Factors with Retention of Children in a Long-term Pediatric HIV Cohort Study

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2008 Apr 17
PMID 18413359
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Minimizing loss to follow-up (LTFU) in long-term cohort studies is essential for reducing bias and maintaining statistical stability. However, factors associated with attrition of children in observational studies have received little attention. The authors used survival analysis methods to evaluate the association of participant and site characteristics with time to LTFU in a multicenter cohort study conducted in the United States of 2,693 human immunodeficiency virus (HIV)-infected and 1,370 HIV-exposed-but-uninfected children enrolled in 2000-2004. As of 2004, 91% of HIV-infected and 86% of uninfected children had been retained in the study. Among the HIV infected, factors associated with higher risk of LTFU included site prohibition of participant compensation, low caregiver educational level, age >15 years, and higher viral load, whereas death of a family member was associated with better retention. Among uninfected children, sites accruing low numbers of subjects, social worker responsible for retention, young age (1-2 years), and birth abnormalities were associated with higher risk of LTFU. Occurrences of certain stressful life events, such as a death in the family or financial instability, were associated with higher retention, but risk of LTFU increased when children started school or mothers began employment. Although participant characteristics are difficult to modify, the authors identified several potentially modifiable site practices that could be targeted to improve retention.

Citing Articles

Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemic.

LeCroy M, Potter L, Bandeen-Roche K, Bianco M, Cappola A, Carter E J Clin Transl Sci. 2023; 7(1):e38.

PMID: 36845306 PMC: 9947617. DOI: 10.1017/cts.2022.510.


Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation.

Panayidou K, Davies M, Anderegg N, Egger M J Int AIDS Soc. 2019; 21(11):e25200.

PMID: 30614622 PMC: 6275813. DOI: 10.1002/jia2.25200.


Does Economic Strengthening Improve Viral Suppression Among Adolescents Living with HIV? Results From a Cluster Randomized Trial in Uganda.

Bermudez L, Ssewamala F, Neilands T, Lu L, Jennings L, Nakigozi G AIDS Behav. 2018; 22(11):3763-3772.

PMID: 29846836 PMC: 6204092. DOI: 10.1007/s10461-018-2173-7.


Demographic and Operational Factors Predicting Study Completion in a Multisite Case-Control Study of Preschool Children.

Bradley C, Browne E, Alexander A, Collins J, Dahm J, DiGuiseppi C Am J Epidemiol. 2018; 187(3):592-603.

PMID: 29506195 PMC: 5963499. DOI: 10.1093/aje/kwx262.


Pediatric HIV care and treatment services in Tanzania: implications for survival.

Somi G, Majigo M, Manyahi J, Nondi J, Agricola J, Sambu V BMC Health Serv Res. 2017; 17(1):540.

PMID: 28784131 PMC: 5547461. DOI: 10.1186/s12913-017-2492-9.


References
1.
ORR P, Blackhurst D, Hawkins B . Patient and clinic factors predictive of missed visits and inactive status in a multicenter clinical trial. The Macular Photocoagulation Study Group. Control Clin Trials. 1992; 13(1):40-9. DOI: 10.1016/0197-2456(92)90028-x. View

2.
Dudley J, Jin S, Hoover D, Metz S, Thackeray R, CHMIEL J . The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol. 1995; 142(3):323-30. DOI: 10.1093/oxfordjournals.aje.a117638. View

3.
Neill K, Chessa F . Recruitment and retention of women in nontherapeutic clinical trials. Appl Nurs Res. 1998; 11(3):148-51. DOI: 10.1016/s0897-1897(98)80152-3. View

4.
Conwell D, Mosher A, Khan A, Tapy J, Sandman L, Vernon A . Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22). Contemp Clin Trials. 2006; 28(3):288-94. DOI: 10.1016/j.cct.2006.09.003. View

5.
Seage 3rd G, Holte S, Metzger D, Koblin B, Gross M, Celum C . Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study. Am J Epidemiol. 2001; 153(7):619-27. DOI: 10.1093/aje/153.7.619. View